Bath & Body Works Affirms Q4 GAAP EPS Guidance of $1.41-$1.61 vs $1.71 Est; Sees Sales $2.574B-$2.670B vs $2.666B Est
Benzinga Newsdesk 1 day ago
NewsGuidance
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Bath & Body Works (NYSE:BBWI) affirms Q4 GAAP EPS guidance from $1.41-$1.61 to $1.41-$1.61 vs $1.71 analyst estimate. sees sales of $2.574 billion-$2.670 billion vs $2.666 billion analyst estimate.
More on BBWI
Analyst ratings Benzinga
UBS Maintains Neutral on Bath & Body Works, Lowers Price Target to $19UBS analyst Jay Sole maintains Bath & Body Works (NYSE:BBWI) with a Neutral and lowers the price target from $22 to $19.
Analyst ratings Benzinga
JP Morgan Maintains Neutral on Bath & Body Works, Lowers Price Target to $23JP Morgan analyst Matthew Boss maintains Bath & Body Works (NYSE:BBWI) with a Neutral and lowers the price target from $24 to $23.
Analyst ratings Benzinga
B of A Securities Maintains Buy on Bath & Body Works, Lowers Price Target to $25B of A Securities analyst Lorraine Hutchinson maintains Bath & Body Works (NYSE:BBWI) with a Buy and lowers the price target from $30 to $25.
Earnings Benzinga
Bath & Body Works Analysts Slash Their Forecasts After Q3 EarningsBath & Body Works beat Q3 estimates and raised FY26 sales outlook, but cut GAAP EPS guidance and gave weak Q4 forecasts; analysts lowered price targets.

Analyst ratings Benzinga
BMO Capital Maintains Market Perform on Bath & Body Works, Lowers Price Target to $20BMO Capital analyst Kelly Crago maintains Bath & Body Works (NYSE:BBWI) with a Market Perform and lowers the price target from $24 to $20.
Analyst ratings Benzinga
Wells Fargo Maintains Overweight on Bath & Body Works, Lowers Price Target to $24Wells Fargo analyst Ike Boruchow maintains Bath & Body Works (NYSE:BBWI) with a Overweight and lowers the price target from $25 to $24.
